UK looks to en­sure phar­ma sub­mis­sions can con­tin­ue un­der no deal Brex­it

The UK’s Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency (MHRA) is prepar­ing to en­sure that if the UK leaves the EU with­out a deal, phar­ma­ceu­ti­cal com­pa­nies can con­tin­ue to sub­mit reg­u­la­to­ry and no­ti­fi­ca­tion in­for­ma­tion to the UK.

“If the UK leaves the EU with no deal, the UK would no longer be part of the EU med­i­cines and med­ical de­vices reg­u­la­to­ry net­works. Sub­mis­sions re­lat­ed to hu­man med­i­cines would need to be sub­mit­ted di­rect­ly to the MHRA,” the agency said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER